Data / Form D filings / GENECURE LLC
GENECURE LLC: Form D filing
GENECURE LLC, a biotechnology company in Norcross, GA, filed a Form D with the SEC in 2014. The latest, on February 21, 2014, reports $2 million sold of a $5 million offering to 20 investors.
Find out what GENECURE LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3150 CORNERS NORTH COURT, Norcross, GA, 30071
- Phone
- (770) 263-7508
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 504, Rule 505, Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1079273
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2014 | New notice | $4,999,999 | $2,000,000 | $2,999,999 | 20 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| frank tung | Promoter |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Feb 17, 2014 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENECURE LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.